Metastatic urothelial cell carcinoma

Also known as: Metastatic Urothelial Carcinoma (UC) / Metastatic Urothelial Carcinoma / Metastatic urothelial carcinoma (disorder)

DrugDrug NameDrug Description
DB09035NivolumabA PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DB00642PemetrexedA folate analog used to treat mesothelioma and non-small cell lung cancer.
DrugDrug NamePhaseStatusCount
DB08947Iopamidol0Completed1
DB12565Abexinostat1Completed1
DB05015Belinostat1Recruiting1
DB00112Bevacizumab1Active Not Recruiting1
DB08875Cabozantinib1Active Not Recruiting1
DB08875Cabozantinib1Recruiting1
DB00002Cetuximab1Active Not Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB11714Durvalumab1Recruiting1
DB13007Enfortumab vedotin1Active Not Recruiting1
DB13007Enfortumab vedotin1Recruiting2
DB12147Erdafitinib1Recruiting1
DB06186Ipilimumab1Recruiting1
DB14123Menthol1Active Not Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB09035Nivolumab1Completed1
DB01229Paclitaxel1Recruiting1
DB09037Pembrolizumab1Completed1
DB09037Pembrolizumab1Recruiting2
DB12893Sacituzumab govitecan1Active Not Recruiting1
DB00020Sargramostim1Recruiting1
DB00877Sirolimus1Active Not Recruiting1
DB09143Sonidegib1Recruiting1
DB06287Temsirolimus1Active Not Recruiting1
DB18314Valemetostat1Recruiting1
DB00313Valproic acid1Active Not Recruiting1
DB11595Atezolizumab1 / 2Terminated1
DB00531Cyclophosphamide1 / 2Terminated1
DB00997Doxorubicin1 / 2Active Not Recruiting1
DB13007Enfortumab vedotin1 / 2Active Not Recruiting1
DB08871Eribulin1 / 2Active Not Recruiting1
DB01175Escitalopram1 / 2Recruiting1
DB16729Favezelimab1 / 2Active Not Recruiting1
DB01073Fludarabine1 / 2Terminated1
DB00441Gemcitabine1 / 2Active Not Recruiting1
DB06186Ipilimumab1 / 2Active Not Recruiting1
DB09570Ixazomib1 / 2Active Not Recruiting1
DB09035Nivolumab1 / 2Active Not Recruiting1
DB09037Pembrolizumab1 / 2Active Not Recruiting2
DB09037Pembrolizumab1 / 2Recruiting1
DB12893Sacituzumab govitecan1 / 2Active Not Recruiting1
DB11942Selinexor1 / 2Recruiting1
DB12887Tazemetostat1 / 2Active Not Recruiting1
DB16420Vibostolimab1 / 2Active Not Recruiting1
DB11703Acalabrutinib2Completed1
DB00640Adenosine2Recruiting1
DB00062Albumin human2Completed1
DB00041Aldesleukin2Recruiting1
DB11595Atezolizumab2Active Not Recruiting1
DB11595Atezolizumab2Terminated1
DB11945Avelumab2Active Not Recruiting1
DB11945Avelumab2Recruiting2
DB11945Avelumab2Withdrawn1
DB01128Bicalutamide2Withdrawn1
DB08875Cabozantinib2Active Not Recruiting1
DB00958Carboplatin2Terminated1
DB14917Ceralasertib2Recruiting1
DB12109Devimistat2Recruiting1
DB11714Durvalumab2Recruiting1
DB13007Enfortumab vedotin2Recruiting1
DB00544Fluorouracil2Recruiting1
DB00441Gemcitabine2Recruiting1
DB00441Gemcitabine2Terminated1
DB01611Hydroxychloroquine2Recruiting1
DB11997Interleukin-72Active Not Recruiting1
DB00166Lipoic acid2Recruiting1
DB09035Nivolumab2Recruiting3
DB09035Nivolumab2Terminated1
DB09074Olaparib2Recruiting1
DB01229Paclitaxel2Completed1
DB09073Palbociclib2Terminated1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Completed2
DB09037Pembrolizumab2Recruiting5
DB09037Pembrolizumab2Terminated2
DB09037Pembrolizumab2Withdrawn1
DB00642Pemetrexed2Active Not Recruiting1
DB00642Pemetrexed2Terminated1
DB15102Pemigatinib2Terminated1
DB00571Propranolol2Recruiting1
DB14851Relatlimab2Recruiting1
DB15073Ribose2Recruiting1
DB12332Rucaparib2Terminated1
DB14797SEphB4-HSA2Recruiting1
DB11836Sapanisertib2Active Not Recruiting1
DB17391Trastuzumab vedotin2Recruiting1
DB17575Utidelone2Recruiting1
DB11595Atezolizumab3Active Not Recruiting1
DB11945Avelumab3Active Not Recruiting1
DB00112Bevacizumab3Completed1
DB14547Chloride ion3Completed1
DB00515Cisplatin3Completed1
DB01248Docetaxel3Recruiting1
DB11714Durvalumab3Active Not Recruiting1
DB08871Eribulin3Recruiting1
DB00441Gemcitabine3Completed1
DB00441Gemcitabine3Recruiting1
DB09035Nivolumab3Active Not Recruiting1
DB01229Paclitaxel3Recruiting1
DB09037Pembrolizumab3Active Not Recruiting1
DB12257Platinum3Completed1
DB12893Sacituzumab govitecan3Recruiting1
DB11945AvelumabNot AvailableCompleted1
DB12147ErdafitinibNot AvailableTerminated1